Ann: Preliminary Final Report for period to 31 December 2018, page-18

Hi Al, btw short for Al Capone? lol.

Your second para, that would be the worst case scenario if that happened, imo.

Adapt the Crown and TAVR the jewel in the Crown, TAVR once successfully commercialised, (years in the making)  IF successful, it would be the Crown.


Myself; glad to see the back of the vaccine division, at least the crippling R&D costs that forever ‘helped’ doomed this company to its present postion ....., massive share dilution etc etc.

That is not even signed off yet, wtf!.

Imo, worst case scenario is this; further CR due to Admedus failing to come up with sufficient funds to ‘keep lights on’, by this time Admedus will be largely owned by SB and SIO, with 85 % ownership plus, .....retail investors outlook??

Very, very, damaging would be the exit of one of these parties.

SB versus SIO ...... amicable or hostile, absolutely need a hostile relationship for some relief to retail holders, as in sp appreciation.

Amicable; all over red rover, SB land on their feet, SIO land on their feet and of course WP lands on his feet, imo.

Left field events; influx of new retail holders, (unlikely) OR third party entering the ‘fray’, would, imo, be a ‘rainmaker’ of a event by WP, that would be at least possible???

Meanwhile the comment by WP that this year has been difficult?? Try last few years, especially since under his control, that is a fact.

Here is a company with cutting edge IP, revenue at 20 mill plus yet with a sp at less than half a cent (pre-consolidation)!!! Wtf????

Said for years there may be something amiss, though ‘sucked in’ at one stage that things were ‘turned around’ .... sp was pumped up to 34 cents plus, .... famous ‘last words’!!  

What a cluster huck it has been for retail investors to have invested in this company, despite CodeRed, super postive twitter etc etc, only thing we can look forward too is to ‘minimise’ our significant losses.